Ekso Bionics (EKSO)
(Delayed Data from NSDQ)
$1.00 USD
-0.05 (-4.76%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $1.03 +0.03 (3.00%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
EKSO 1.00 -0.05(-4.76%)
Will EKSO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for EKSO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for EKSO
Ekso Bionics (EKSO) Reports Q2 Loss, Lags Revenue Estimates
Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices
EKSO: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Ekso Bionics (EKSO) Rating Upgrade to Buy
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Here's Why Ekso Bionics (EKSO) Is a Great 'Buy the Bottom' Stock Now
Other News for EKSO
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Crude Oil Down 1%; Procter & Gamble Shares Fall After Q4 Results
Lake Street Sticks to Its Buy Rating for EKSO BIONICS (EKSO)
Why Is Imunon (IMNN) Stock Up 259% Today?
Why Is Ekso Bionics (EKSO) Stock Down 15% Today?